Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Aage Wamberg

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|March 31, 2023
Mathilde Fahrendorff, Dorte Fris Palmqvist, Christian Aage Wamberg, et al.
Acta Anaesthesiologica Scandinavica|May 19, 2025
Respiratory Failure Requiring Mechanical Ventilation Among Patients Receiving Chlordiazepoxide for Alcohol Withdrawal SymptomsNanna Reiter, Helena Roed Otte, Kim Dalhoff, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 4, 2026
A prospective pharmacokinetic study of chlordiazepoxide in patients admitted to an intensive care unit or a high dependency unit after treatment of alcohol withdrawal symptomsNanna Reiter, Kim Dalhoff, Tonny Studsgaard Petersen, et al.
Brain : a Journal of Neurology|June 12, 2025
Stimulants for disorders of consciousness in the intensive care unit: a randomized, placebo-controlled trialMarwan H Othman, Attila Géry Toury-Puel, Karen Irgens Tanderup Hansen, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|March 31, 2023
Mathilde Fahrendorff, Dorte Fris Palmqvist, Christian Aage Wamberg, et al.
Acta Anaesthesiologica Scandinavica|May 19, 2025
Respiratory Failure Requiring Mechanical Ventilation Among Patients Receiving Chlordiazepoxide for Alcohol Withdrawal SymptomsNanna Reiter, Helena Roed Otte, Kim Dalhoff, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 4, 2026
A prospective pharmacokinetic study of chlordiazepoxide in patients admitted to an intensive care unit or a high dependency unit after treatment of alcohol withdrawal symptomsNanna Reiter, Kim Dalhoff, Tonny Studsgaard Petersen, et al.
Brain : a Journal of Neurology|June 12, 2025
Stimulants for disorders of consciousness in the intensive care unit: a randomized, placebo-controlled trialMarwan H Othman, Attila Géry Toury-Puel, Karen Irgens Tanderup Hansen, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Pageof 1